Recent declines in overdose deaths across the nation suggest the opioid crisis may be reaching a plateau after years of mounting mortality. Overdose deaths fell 27 percent nationwide in 2024 from prior levels and are at or below prepandemic levels nationally, though Texas drug deaths fell 12 percent in 2024 after peaking in 2023 and remain above prepandemic levels.
Regional Variations and Texas Profile
The opioid crisis has affected states with widely varying intensity. Texas had an average drug-related mortality rate of 11 deaths per 100,000 from 1999-2023, less than one-third that of West Virginia, which averaged 36 deaths per 100,000 over the same period. In 2022, Texas averaged 19 deaths per 100,000 while West Virginia reached 79 per 100,000. Texas’s lower rate may be explained by comparatively lower fentanyl uptake—only 34 percent of Texas overdoses between 2019 and 2023 involved fentanyl, nearly half the national rate of 62 percent. A larger Hispanic population, comprising 40 percent of Texas’s population, may also contribute; in 2022, non-Hispanic Texans died at a rate of 23 per 100,000 compared to 13 per 100,000 for Hispanics. Favorable economic factors including plentiful opportunity and low unemployment may also play a role.
Treatment and Harm Reduction Approaches
Effective harm-reduction strategies include access to naloxone (Narcan) and buprenorphine treatment. States with Narcan access laws experienced a 9 to 10 percent decline in opioid mortality after implementation. Users treated with methadone and buprenorphine have less than one-third the overdose risk of untreated users. Texas implemented naloxone access in 2015 and passed its Good Samaritan Law in 2021. Texas established the Opioid Abatement Fund Council in 2021 to distribute $1.6 billion over an 18-year period from a multi-state lawsuit settlement with pharmaceutical companies.
Current Crisis Evolution
In 2024, 3.0 percent of Americans misused opiates, down from 3.6 percent in 2021. The opioid supply has evolved from prescription drugs in the 1990s, followed by heroin, to synthetic fentanyl dominance. By 2024, 82 percent of those who abused fentanyl used illegally-made fentanyl, up from 69 percent in 2022. Authorities must remain vigilant for emerging threats including nitazenes, a family of drugs circulating in Europe that are considerably more potent than fentanyl.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.dallasfed.org/research/swe/2025/swe2516